Hennion & Walsh Asset Management, Inc. Zai Lab LTD Transaction History
Hennion & Walsh Asset Management, Inc.
- $1.89 Billion
- Q2 2024
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Zai Lab LTD stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 124,096 shares of ZLAB stock, worth $2.32 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
124,096
Previous 63,169
96.45%
Holding current value
$2.32 Million
Previous $1.01 Million
112.66%
% of portfolio
0.11%
Previous 0.06%
Shares
5 transactions
Others Institutions Holding ZLAB
# of Institutions
122Shares Held
39.7MCall Options Held
41.2KPut Options Held
190K-
Wellington Management Group LLP Boston, MA6.66MShares$124 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA5.68MShares$106 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X04.43MShares$82.6 Million0.04% of portfolio
-
Woodline Partners LP San Francisco, CA2.6MShares$48.5 Million0.4% of portfolio
-
Viking Global Investors LP2.05MShares$38.2 Million0.12% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $1.83B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...